Newly found sensing system enables certain bacteria to resist human immune defensesJune 08, 2007Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, have discovered a survival mechanism in a common type of bacteria that can cause illness. The mechanism lets the bacteria protect itself by warding off attacks from antimicrobial peptides (AMPs), which are defense molecules sent by the body to kill bacteria. Bacteria are divided into two types, gram-positive and gram-negative, with the primary difference being the nature of the bacterial cell wall. Little is known about how gram-positive bacteria-such as those that can lead to food poisoning, skin disorders and toxic shock-avoid being killed by AMPs. AMPs are made by virtually all groups of organisms, including amphibians, insects, several invertebrates and mammals, including humans. "Gram-positive bacteria are major threats to human health, especially due to increasing problems with drug resistance, and these findings may help chart a path to designing new drugs to bolster our antimicrobial treatment options," notes NIAID Director Anthony S. Fauci, M.D.
Led by Michael Otto, Ph.D., of NIAID's Rocky Mountain Laboratories (RML), the scientists used the gram-positive bacterium Staphylococcus epidermidis to study its response to a specific human AMP, human beta defensin 3. S. epidermidis is one of several hard-to-treat infectious agents that can be transmitted to patients in hospitals via contaminated medical implants. Findings by Dr. Otto's research group are published in the May 29 issue of the Proceedings of the National Academy of Science. Other well-known types of gram-positive bacteria include agents that cause anthrax, strep throat, flesh-eating disease and various types of food poisoning. In gram-negative bacteria-such as those that cause plague and salmonellosis-a sensory and gene regulation system named PhoP/PhoQ protects invading bacteria, and scientists believe if they develop a better understanding of this system they could develop new drugs that are more effective at protecting people from infection. Likewise, now Dr. Otto and his research group are hoping for similar possibilities for gram-positive bacteria with their discovery of "aps," which stands for antimicrobial peptide sensor. Aps has three parts: apsS, the sensor region; apsR, the gene regulation region; and apsX, which has an unknown function that Dr. Otto's group is investigating. Studies show that all three components of aps must be present for the system to function and effectively protect bacteria from AMPs. "We are aware that for gram-negative bacteria, PhoP/PhoQ has been called a premier target for antimicrobial drug discovery, but little corresponding work has been done with gram-positive bacteria," Dr. Otto says. "Our group is excited by what we have demonstrated-an efficient and unique way that gram-positive bacteria control resistance-and we are continuing our investigation of the aps sensing system being used for drug development." NIH/National Institute of Allergy and Infectious Diseases | |||||||||||||||||||||
|
Related Immune Defense Current Events and Immune Defense News Articles How flesh-eating bacteria attack the body's immune system "Flesh-eating" or "Strep" bacteria are able to survive and spread in the body by degrading a key immune defense molecule, according to researchers at the University of California, San Diego, School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences. Umbilical cord blood cell transplants may help ALS patients A study at the University of South Florida has shown that transplants of mononuclear human umbilical cord blood (MNChUCB) cells may help patients suffering from Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. Weight loss after gastric bypass surgery may protect against infection and cancer Another health benefit of bariatric weight-loss surgery may be a heightened immune defense against cancer and infections, a new study suggests. The results will be presented at The Endocrine Society's 90th Annual Meeting in San Francisco. Immune system pathway identified to fight allergens, asthma For the first time, researchers from the University of Pittsburgh School of Medicine have identified genetic components of dendritic cells that are key to asthma and allergy-related immune response malfunction. Breast cancers behave differently before and after the age of 70 Researchers in Belgium have discovered that increasing age affects the way breast cancer behaves. As women approach the age of 70, they become less likely to be diagnosed with aggressive tumours that have spread to the lymph nodes. But after 70, the cancer is increasingly likely to spread, particularly if the tumours are small. Fruit flies show how salmonella escapes immune defenses Salmonella are wily and obnoxious bacterial invaders--escape artists capable of evading multiple immune responses and causing a harsh and debilitating intestinal infection. Customized treatments for sepsis lower treatment time and reduce length of ICU stays Using a blood test and a decision algorithm, rather than standard hospital protocols, to determine the appropriate length of antibiotic therapy in patients with severe sepsis or septic shock can reduce duration of treatments, shorten ICU stays, and lower hospital costs- all without adverse effects on patients, according to new research. Several genes that regulate the disease SLE have been identified Swedish researchers, in collaboration with foreign colleagues, have identified a number of new genes that can be tied to the disease SLE, including a gene that hopefully might be used to treat the disease in the future by regulating the production of antibodies. Factor key to severity of community-associated methicillin-resistant staph infections identified Newly described proteins in drug-resistant strains of the Staphylococcus aureus bacterium attract and then destroy protective human white blood cells-a key process ensuring that S. aureus survives and causes severe disease. Glue inside the cell: Ubiquitin builds up an immune response Ubiquitin is a small protein, which can be attached to other cellular proteins, a process known as ubiquitination. Discoveries in the 1980 th on a key function of ubiquitination in the regulation of protein degradation where awarded with the Nobel Prize for chemistry in 2004. More Immune Defense Current Events and Immune Defense News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||